Coronary Stents Market Report

The global coronary stents market witnesses high contribution of Western Europe and North America to the introduction of high-end products. The competitive landscape could be largely concentrated with top three players securing a major collective share of the global market. Some of the important strategies that manufacturers could adopt to gain a competitive edge over other players are tactical partnerships and mergers and acquisitions. High requirement of coronary stents in percutaneous coronary intervention could be a key growth factor of the global market. Increasing use of coronary stents due to high prevalence of cardiovascular disease is predicted to support the global market growth. Availability of promising reimbursement policies could be another factor working in the favor of the global market.

QYR Consulting expects the global coronary stents market to expand at a CAGR of xx% during the forecast period 2019-2025. By 2025, the global market size is projected to reach US$xx Mn. In 2018, it touched around US$xx Mn. The report digs deep into the growth potential, dynamics, production, consumption, and other factors impacting the global market growth.

Market Dynamics

Development of technologically sophisticated coronary stents, increasing geriatric population, and rising incidence of coronary artery disease are some of the vital factors anticipated to add strength to the growth of the global coronary stents market. High adoption of miniaturized and advanced coronary stents could be attributed to the strong demand for minimally invasive surgical procedures. Use of these types of coronary stents help with faster healing, reduced hospital stays, and less complications and trauma after the procedure. Increased demand for drug-eluting stent because of its high technological development and use in patients who experienced acute ST-segment-elevation myocardial infarction (STEMI) is predicted to improve the global market growth.

Market Segments

The global coronary stents market is segmented by product type and application. The product type segments studied in the report are bioresorbable vascular scaffold, drug-eluting stent, and bare-metal stent. Key applications analyzed in the report are cardiology centers, hospitals, and ambulatory surgery centers.

By Region

Key Players

The report includes company profiling of leading players of the global coronary stents market such as Boston Scientific, Essen Technology, Biosensors, LBC, Terumo, SINOMED, MicroPort, Atrium Medical, Lepu Medical, and B. Braun.

Life sciences is a wide branch of study that is gradually becoming an integral industry to the global economics. QYR Consulting looks at the steady transformation of the life sciences industry and its impact on the subindustries such as medical care, pharmaceutical, and medical devices. Our team of esteemed analysts have put together reports to analyze the monumental changes life sciences is expected to bring in the overall healthcare industry. These reports identify the exact turning points for the industry and open up a platform for discussing its growth.

QYR Consulting brings to you a structured analysis of the technological advancements so far, vision of the players in the industry, and the strategies they are likely to use to make their mark. The reports dissect various components of the life sciences industry to scrutinize the influential factors. To help the readers make profitable business decisions, analysts have highlighted the lucrative investment areas and upcoming business opportunities.